Everett Capital Advisors (UK)’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
LP
Everett Capital Advisors (UK)'s AGN Position: Q4 2019 in Review
Everett Capital Advisors (UK) sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 64,500 shares — an estimated $10.9M sold.
Everett Capital Advisors (UK) first reported a position in AGN in Q2 2019 and held it in 2 quarters. The position peaked at $10.9M in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.
- Everett Capital Advisors (UK) reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
- Everett Capital Advisors (UK) sold 64,500 Allergan plc shares in Q4 2019, an estimated $10.9M.
- Everett Capital Advisors (UK) first reported a position in Allergan plc in Q2 2019 and held it in 2 quarters.
- Everett Capital Advisors (UK)'s Allergan plc position peaked at $10.9M in Q3 2019.
- 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.
Based on Everett Capital Advisors (UK)'s 13F filing for Q4 2019, filed 15 Jan 2020.